ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

People

Magid Abou-Gharbia Wins Whalen Award

by Linda Wang
October 3, 2011 | APPEARED IN VOLUME 89, ISSUE 40

Magid Abou-Gharbia, director of the Moulder Center for Drug Discovery Research at Temple University, is the winner of the 2011 Henry F. Whalen Jr. Award for Excellence in Business Development from the American Chemical Society Division of Business Development & Management.

Abou-Gharbia was cited for his ability to build and lead multidisciplinary research teams and to foster a highly creative R&D environment. His work has led to the discovery of six marketed drugs, such as Effexor, Pristiq, Torisel, and Tygacil, and many drug candidates under clinical evaluation.

Prior to joining Temple in 2008, Abou-Gharbia spent 26 years at Wyeth Pharmaceuticals (now Pfizer), where he was senior vice president and head of chemical and screening sciences. At Temple, he also serves as associate dean for research and is a professor of medicinal chemistry. Abou-Gharbia received the award during the fall ACS national meeting in Denver.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment